Akero Therapeutics Price Target Announced at $65.00/Share by Citigroup Dow Jones·11/18/2024 20:51 More About AKRO More Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical...
8K AKRO Stock Analysis & Ideas 3 Best Stocks to Buy Now, 12/20/2023, According to Top Analysts 1y ago AKRO ARVN More AKRO News > AKRO News on the Web All News Bearish News Bullish News 27 days ago Analysts’ Top Healthcare Picks: Opus Genetics (IRD), Elevation Oncology (ELEV) ...
$15.68$15.68 $7.84 per Count ($7.84$7.84 / Count) FREE delivery January 7 - 9. Details Select delivery location In Stock Quantity: Quantity:1 Add to Cart Buy Now Other sellers on Amazon New (6) from $15.68$15.68 & FREE Shipping ...
Shop Akro-Mils storage bins and organization products at Markertek. Large in stock inventory, safe secure checkout & award winning lifetime customer support.
Why Akero Therapeutics Stock Is Crashing Today Investors are bailing on the biotech stock after disappointing clinical results for experimental NASH drug efruxifermin (EFX). Keith Speights | Oct 10, 2023 Why Akero Therapeutics Stock Is on Fire Today George Budwell | Sep 13, 2022 The biotech...